Market revenue in 2023 | USD 2,057.3 million |
Market revenue in 2030 | USD 5,702.0 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | Chromatography systems |
Fastest growing segment | Filters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers |
Key market players worldwide | Merck KGaA, Sartorius AG, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Danaher Corp, Repligen Corp, 3M Co, Boehringer Ingelheim, Corning Inc, Lonza Group Ltd, Dover Corp, Asahi Kasei Corp, Eppendorf |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to downstream processing market will help companies and investors design strategic landscapes.
Chromatography systems was the largest segment with a revenue share of 42.23% in 2023. Horizon Databook has segmented the India downstream processing market based on chromatography systems, filters, evaporators, centrifuges, dryers covering the revenue growth of each sub-segment from 2018 to 2030.
India is a key destination for bioprocess outsourcing and raw materials for bio manufacturing. The country’s biotechnology industry has gained global attention in the past few years and has the potential to become one of the most preferred destinations for global pharmaceuticals manufacturing outsourcing.
In addition, India is one of the key countries where there is high demand for biopharmaceuticals, along with growing healthcare infrastructure, support from government, and cheap land & labor costs when compared to developed western countries. Therefore, these factors have attracted many global biopharma players to invest into the Indian market to expand their business offerings.
Hence, this market has witnessed collaborative programs, partnerships, acquisitions, and other deals into innovative biomanufacturing, R&D, and clinical trials for biologics. In addition, the country offers lucrative growth opportunities for downstream processing market in the form of growth prospects offered by vaccines, biosimilars, and regenerative medicines.
Horizon Databook provides a detailed overview of country-level data and insights on the India downstream processing market , including forecasts for subscribers. This country databook contains high-level insights into India downstream processing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account